Navigation Links
Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights
Date:2/26/2009

' Form 10-K for the year ended December 31, 2007 and Anadys' Form 10-Q for the quarter ended September 30, 2008. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

    Condensed Consolidated Financial Statements

                           Anadys Pharmaceuticals, Inc.
                Condensed Consolidated Statements of Operations
                    (In thousands except per share amounts)
                                   (Unaudited)

                                    Three Months Ended   Twelve Months Ended
                                         December 31,        December  31,
                                        2008      2007      2008      2007

    Revenues                              $-      $225        $-   $24,118

    Operating expenses
      Research and development (1)     6,902     6,917    25,993    28,192
      General and administrative       2,005     1,847     8,109     8,692
    Total operating expenses (2)       8,907     8,764    34,102    36,884

    Interest income and other, net       389       739     1,700     3,594

    Net loss (2)                     $(8,518)  $(7,800) $(32,402)  $(9,172)

    Net loss per share, basic and
     diluted (2)                      $(0.30)   $(0.27)   $(1.13)   $(0.32)

    Share used in calculating net
     loss per share, basic and
     diluted                          28,797    28,674    28,750    28,646


    (1)  Includes $36 as additional research and development expense, which
         represents an estimate of the net payable due to Novartis of
         ANA975 research and development costs for the three months ended
         December 31, 2007.  Includes ($50) a
'/>"/>
SOURCE  Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 

Related medicine news :

1. Anadys Pharmaceuticals to Present at BIO InvestorForum 2007
2. Anadys Pharmaceuticals to Present at Bio Investor Forum
3. Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
4. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
5. Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2008 Financial Results
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... France: One-year results from SOURCE XT one of ... to-date reported today at EuroPCR 2013 show good ... of device success for all access approaches, valve sizes ... followed up 2688 consecutively enrolled patients (mean age 81.5 ... at 93 centres in 17 countries between July 2010 ...
(Date:5/21/2013)... Arizona State University is seeking aspiring ... their ideas into solutions, products and services in ... is recruiting participants for AREA48 (Applied Regional Economic ... early-stage entrepreneurs with opportunities to access human and ... ASU is particularly seeking participation from retirees, veterans ...
(Date:5/21/2013)... The federal judge overseeing the litigation ... lawsuits in U.S. District Court, Northern District of Georgia, ... from Plaintiffs’ Counsel to conduct Ex Parte interviews with ... Order grants that request, and sets forth procedures under ... Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation, ...
(Date:5/21/2013)... Phoseon Technology will present their advanced ... Annual IMI European Ink Jet Conference (June 5-6, ... continues to invest in product development to enable breakthrough ... LED curing in printing applications. Phoseon currently has ... offering both air cooled and water cooled solutions to ...
(Date:5/21/2013)... 21, 2013 Global Proving Ground (GPG), ... the largest online retailer of health and fitness supplements, ... sports show, Warrior Island. “We cast the show ... & Twitter, with our unique social networking platform,” states ... elite fighters on an island in the Pacific Ocean, ...
Breaking Medicine News(10 mins):Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3
... Center have identified and announced the most common causes ... with red, sore itchy rashes was caused by exposing ... fragnance, cosmetics, metals, creams, etc. ,The July ... 10 causes of contact dermatitis that were recently identified ...
... tests conducted by the Analytical Services Tasmania King Island's water ... conducted tests which showed high content of lead in the ... testing done by the council which found no problem with ... metals and the results were announced with days of testing. ...
... report of the Washington Post, the department of health of Washington, ... every district resident, between 14years and 84years, to ... , The launching of the campaign, to be named ... the 12th annual National HIV Testing Day. ,Gregg Pane, ...
... (AIIMS) dean is considering quitting the institution //, as ... colleagues and misguided students. ,The dean R.C.Deka, ... expert in cochlear implant surgery is now contemplating leaving ... by his colleagues and students. He explained that he ...
... in their new studies that the analysis of the placenta ... ,Scientists from the University of Yale stated that they believe ... birth by analysing and seeking out certain biological abnormalities present ... developmental disorder that affects a child's social learning and communication ...
... Varca in Goa it is found that Indians eating ... //The two day conference mainly analyzed the Indian population ... This would further worsen the situation by increasing the ... diabetes and other fatal diseases. Experts and medical practitioners ...
Cached Medicine News:Health News:Another Senior Doctor From AIIMS Contemplates Leaving Due to Infighting 2Health News:Another Senior Doctor From AIIMS Contemplates Leaving Due to Infighting 3Health News:Analysis of Placenta Helps In Diagnosis of Autism At Birth 2
(Date:5/21/2013)... 21, 2013  Armada Health Care (Armada) is ... Armada corporate website ( www.armadahealthcare.com ).  This new ... and first-to-market services and its position as the ... specialty pharmacy industry. The updated website ... business model in delivering an extensive portfolio of ...
(Date:5/21/2013)... Calif. , May 21, 2013 /PRNewswire/ ... embedded-ultrasound platform, today announced the introduction of ... allows complete network-based communications with all cQuest ... latest embedded-ultrasound technology, including this new capability, ... Sao Paulo, Brazil from May ...
(Date:5/21/2013)... Hurel Corporation ("Hurel"), a world-leading provider of ... today announced the appointment of James S. ... of Directors. Dr. MacDonald is the former Executive Vice ... ("SPRI"), which was the pharmaceutical development arm of Schering ... in 2009. Over a career that has ...
Breaking Medicine Technology:Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
... S.C., Oct. 21, 2011 Federal, state and local ... growing biomedical research effort with the dedication of a ... for major diseases. The complex, housing 78 ... traditional research approach by combining scientists from different fields ...
... division of Sanofi (EURONEXT: SAN and NYSE: ... study evaluating the immunogenicity and safety of an investigational ... of age and older. Currently licensed influenza vaccines target ... a given year. The data were presented at the ...
Cached Medicine Technology:MUSC Dedicates New Bioengineering and Drug Discovery Hubs 2Sanofi Pasteur Presents Additional Data on Investigational Quadrivalent Influenza Vaccine 2Sanofi Pasteur Presents Additional Data on Investigational Quadrivalent Influenza Vaccine 3Sanofi Pasteur Presents Additional Data on Investigational Quadrivalent Influenza Vaccine 4Sanofi Pasteur Presents Additional Data on Investigational Quadrivalent Influenza Vaccine 5
A Biplane Pediatric TEE transducer....
Super High Density, multi-frequency, convex array transducer for scanning during craniotomies. Same footprint as the UST-987-7.5 but with stronger penetration for deep cavernous tumors and other deep...
... Super High Density, multi-frequency, linear ... the first company to introduce ... and, as a result, changed ... and true workhorse has withstood ...
... Super High Density, multi-frequency, linear ... "twist on the UST-5536, this ... it sweeps horizontally as well ... axis so that target lesions ...
Medicine Products: